Pharmaceutical Technology

APRIL 17, 2023

Health Canada has accepted Pfizer Canada’s new drug submission for a bivalent respiratory syncytial virus (RSV) vaccine for review. The vaccine will be used to prevent lower respiratory tract disease and severe lower respiratory tract disease caused by RSV in adults aged 60 and above.

Vaccination 162

Vaccination Vaccine Medicine Drugs 162

BioTech 365

NOVEMBER 12, 2020

Sonde Health Launches Self-Serve API that Detects Symptoms of Respiratory Disease from Changes in Voice Sonde Health Launches Self-Serve API that Detects Symptoms of Respiratory Disease from Changes in Voice New Developer Portal enables any organization to quickly, easily, and … Continue reading →

Development 52

Development 52

BioTech 365

NOVEMBER 17, 2020

Philips World COPD Day survey reveals care challenges, telehealth adoption, and increased global awareness surrounding respiratory health Philips World COPD Day survey reveals care challenges, telehealth adoption, and increased global awareness surrounding respiratory health November 17, 2020 Survey confirms COVID-19 … Continue reading → (..)

40

40

BioTech 365

JUNE 13, 2021

Philips issues recall notification* to mitigate potential health risks related to the sound abatement foam component in certain sleep and respiratory care devices Philips issues recall notification* to mitigate potential health risks related to the sound abatement foam component in … Continue reading →

40

40

Pharmaceutical Technology

APRIL 19, 2023

GSK has signed an agreement to buy Canadian late-stage biopharmaceutical company BELLUS Health for $2bn (£1.6bn). GSK expects that the BELLUS Health acquisition will boost its speciality medicines and respiratory pipeline. GSK will buy all the outstanding shares in BELLUS for $14.75 per share in cash.

Medicine 243

Medicine Sales Clinical Development Trials 243

Pharma Mirror

SEPTEMBER 7, 2021

The Hague, Pharmacists must be allowed to do more to manage respiratory conditions in communities if the urgent need to address the harmful effects of air pollution on health is to be met, the International Pharmaceutical Federation (FIP) said today.

245

245

BioTech 365

MAY 20, 2021

Brazilian Health Regulatory Agency (ANVISA) Authorizes Sorrento Phase 2 Pivotal Clinical Trial of COVI-MSC™ in Hospitalized COVID-19 Patients With Acute Respiratory Distress Syndrome Brazilian Health Regulatory Agency (ANVISA) Authorizes Sorrento Phase 2 Pivotal Clinical Trial of COVI-MSC™ in Hospitalized COVID-19 … Continue reading (..)

Clinical Trials 40

Clinical Trials Clinical Trials Trials 40

Scienmag

JANUARY 23, 2022

A study documenting indoor air quality and housing characteristics in 4 isolated First Nations communities in northwestern Ontario found frequent rates of respiratory infections in children under 3 years of age and that high rates of wheezing in this age group were related to poor housing conditions.

65

65

Pharmaceutical Technology

MAY 5, 2023

TFF Pharmaceuticals and the National Institute of Environmental Health Sciences (NIEHS) have signed an agreement for the development of dry powder formulations of high molecular weight hyaluronan (HMW-HA) for respiratory diseases.

Development 162

Development In-Vivo In-Vitro Engineer 162

Pharmaceutical Technology

DECEMBER 21, 2022

This Moderna Innovation and Technology Centre (MITC) is expected to offer access to a locally produced future mRNA vaccine portfolio against respiratory viruses, subject to regulatory evaluation and licensure. Under the collaboration, the company will also back the mRNA health and science ecosystem of the country.

Gene Therapy 351

Gene Therapy Vaccination Vaccine Manufacturing 351

Pharmaceutical Technology

JANUARY 26, 2023

Health Canada has accepted for review Valeo Pharma partner Veru’s new drug submission (NDS-CV) for Covid-19 therapy sabizabulin. Valeo Pharma CEO Steve Saviuk said: “Health Canada’s filing acceptance of Veru’s NDS-CV application for sabizabulin is the first important regulatory milestone in the drug approval process.

Clinical Trials 246

Clinical Trials Clinical Trials Trials Antibody 246

Medical Xpress

MAY 11, 2023

Overuse of antibiotic prescriptions for patients with upper respiratory illnesses at urgent care clinics in the United States has been an ongoing challenge, but a new study led by researchers at two Utah health systems—Intermountain Health and University of Utah Health—finds that a targeted approach utilizing antibiotic stewardship practices significantly (..)

Research 97

Research 97

Medical Xpress

DECEMBER 6, 2022

Flu, respiratory syncytial virus (RSV), and COVID-19 are creating a perfect storm of respiratory disease that is overwhelming the nation's health care systems.

Vaccination 95

Vaccination Vaccine 95

Medical Xpress

NOVEMBER 22, 2022

Researchers at Oregon Health & Science University have found that vitamin C supplementation to pregnant women unable to quit smoking significantly improves airway function and respiratory health in their offspring at 5 years of age.

Research 98

Research 98

NPR Health - Shots

DECEMBER 14, 2022

NPR asked a handful of public health experts how to approach a holiday season with not one but three respiratory pathogens helping fill hospitals: COVID, the flu and RSV. Image credit: Mark J. Terrill/AP)

115

115

pharmaphorum

AUGUST 25, 2022

Indian drugmaker Koye Pharma has partnered with Sonde Health to develop its vocal biomarker technology – which aims to diagnose diseases from voice patterns – for use in chronic obstructive pulmonary disease (COPD). The two companies plan to explore the development of additional vocal biomarkers during the multi-year alliance.

Pharma Companies 84

Pharma Companies Development Medicine 84

pharmaphorum

OCTOBER 19, 2022

The alliance – the first to be announced since Apar’s digital health unit unveiled the platform earlier this month – will focus on patients with respiratory diseases, including asthma and chronic obstructive pulmonary disease (COPD), and will focus initially on the European market although it may be expanded elsewhere in future.

Pharma Companies 81

Pharma Companies Marketing 81

Medical Xpress

MAY 15, 2023

A new study conducted by Helmholtz Munich researchers reveals that ultrafine particles, representing the smallest size fraction of particulate air pollution, might be more dangerous to human health than larger particles. It was now published in the American Journal of Respiratory and Critical Care Medicine.

Medicine 98

Medicine Research 98

Pharmaceutical Technology

OCTOBER 31, 2022

After decades of setbacks, the respiratory syncytial virus (RSV) vaccine field has bounced back with positive Phase III trial results in older adults. There are currently five players in the race, with vaccines in Phase III of development from GlaxoSmithKline (GSK) , Pfizer , Johnson & Johnson , Moderna and Bavarian Nordic.

Vaccination 338

Vaccination Vaccine Marketing Trials 338

Pharmaceutical Technology

APRIL 26, 2023

Companies like AstraZeneca and Novartis have entered the digital inhaler system market by collaborating with the Madison, Wisconsin-based digital health company Propeller Health to connect patients using the devices with an accompanying platform.

Clinical Trials 289

Clinical Trials Clinical Trials Allergies Research 289

Medical Xpress

MAY 15, 2023

A new artificial intelligence analysis of thousands of posts from the popular online discussion forum Reddit reveals that vapers are concerned about e-cigarettes' possible impact on everything from their respiratory, gastrointestinal, and cardiovascular systems to their mental and sexual health and sleep patterns.

105

105

Medical Xpress

NOVEMBER 18, 2022

The Biden administration on Thursday offered assistance to communities and hospitals dealing with a surge in cases of pediatric respiratory illnesses, but it did not declare a national public health emergency.

98

98

NPR Health - Shots

DECEMBER 14, 2022

NPR asked a handful of public health experts how to approach a holiday season with not one but three respiratory pathogens helping fill hospitals: COVID, the flu and RSV. Image credit: Mark J. Terrill/AP)

98

98

Medical Xpress

FEBRUARY 15, 2023

The UK government's proposal to roll England's long term plan for cancer into one strategy covering all major conditions, such as cardiovascular disease, chronic respiratory disease, dementia, mental health conditions, and musculoskeletal disorders is "a catastrophic decision that will cost lives," warn experts in The BMJ.

98

98

Pharmaceutical Technology

APRIL 10, 2023

The Australian Government’s Department of Health and Aged Care has announced the availability of new medicines for graft versus host disease (GVHD), chronic rhinosinusitis, and oesophageal cancer. Chronic rhinosinusitis with nasal polyps can be debilitating causing pain, impacting people sleeping, their mental health and productivity.

Medicine 130

Medicine Production 130

Scienmag

NOVEMBER 9, 2021

Bacteria found in children’s upper respiratory systems could help fight chronic middle ear infections, the leading cause of preventable hearing loss and deafness in Indigenous communities.

Bacteria 97

Bacteria 97

STAT News

APRIL 19, 2023

In the fall of 2022, a tidal wave of respiratory viral illnesses sent children to emergency rooms in droves when enterovirus, respiratory syncytial virus (RSV), and influenza peaked in close succession, bombarding young children who had remained mostly unexposed to these viruses during the most acute years of the Covid pandemic.

Vaccination 98

Vaccination Vaccine Nurses 98

Medical Xpress

FEBRUARY 27, 2023

Exposure to environmental pollutants, such as particulate matter and noise, can significantly contribute to the prevalence of respiratory and cardiovascular diseases. At the same time, pleasant and green environments have shown to reduce the harm of negative exposures and support health through various pathways.

75

75

Scienmag

JUNE 8, 2021

Credit: ATS June 08, 2021 – Christopher Chesley, MD, of the University of Pennsylvania has been named the 2021 ATS Fellowship in Health Equality Award winner for his project “Determining disparities in care quality for patients with acute respiratory failure and sepsis: the role of hospital-wide capacity strain.”

Medicine 97

Medicine 97

Pharmaceutical Technology

OCTOBER 13, 2022

Oncotelic Therapeutics has received a contract from the US Biomedical Advanced Research and Development Authority (BARDA) to develop OT-101 to treat long-term effects of respiratory distress after Covid-19 infection.

Development 182

Development Clinical Trials Clinical Trials Trials 182

Medical Xpress

DECEMBER 22, 2022

Public health experts have been warning of a "tripledemic" of respiratory viruses this fall and winter, so the American Lung Association has some tips for breathing easier this holiday season.

75

75

Medical Xpress

JANUARY 9, 2023

and most places in between highlight the surge in sick patients suffering from respiratory viruses. The so-called "tripledemic" of lung infections including respiratory synclinal virus (RSV), influenza (flu) and COVID-19 (coronavirus) is likely to last throughout the winter season. Newspaper headlines from the U.S. to the U.K.

Bacteria 75

Bacteria Research 75

STAT News

DECEMBER 16, 2022

The percentage of outpatient visits to health care providers that were for respiratory illnesses declined for a second week in a row, CDC’s weekly influenza report, FluView , showed. And the number of people hospitalized for influenza declined in the week ending Dec. 10, as compared to the previous week.

111

111

Drug Discovery World

MARCH 25, 2024

LG AI Research shares our vision to maximise the value of AI and the potential to transform human health. They hope the combined effort will expand the understanding of the function and impact of individual strains on overall respiratory health.

Gene Editing 52

Gene Editing Drugs Genome Genomics 52

Medical Xpress

NOVEMBER 9, 2022

As the days get shorter and the weather colder in the northern hemisphere, health officials have warned of a perfect storm of infectious respiratory diseases over the winter months.

74

74

Medical Xpress

DECEMBER 13, 2022

While a "tripledemic" of RSV, flu and COVID-19 continue to strain health care systems across Texas and the U.S., drug shortages are also complicating patient care during this year's severe respiratory virus season.

Drugs 75

Drugs 75

STAT News

DECEMBER 6, 2022

But now that the pediatric community is facing its own March 2020 with the confluence of Covid-19, influenza, and respiratory syncytial virus (RSV), the response from outside this community has been slow. prioritizes — or more accurately doesn’t prioritize — the health of children. Read the rest…

111

111